116 related articles for article (PubMed ID: 8162165)
1. Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments.
Pizzi M; Arrighi V; Galli P; Memo M; Spano PF
Eur J Endocrinol; 1994 Apr; 130(4):361-5. PubMed ID: 8162165
[TBL] [Abstract][Full Text] [Related]
2. A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.
Pizzi M; Memo M; Benarese M; Simonazzi E; Missale C; Spano PF
Neuroendocrinology; 1990 Apr; 51(4):481-6. PubMed ID: 2161088
[TBL] [Abstract][Full Text] [Related]
3. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
Apfelbaum ME
Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
[TBL] [Abstract][Full Text] [Related]
4. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
Kang SW; Youngren OM; El Halawani ME
Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
6. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
[TBL] [Abstract][Full Text] [Related]
8. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
[TBL] [Abstract][Full Text] [Related]
9. Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture.
Rotsztejn WH; Dussaillant M; Nobou F; Rosselin G
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7584-8. PubMed ID: 6278481
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
Sanyal S; Van Tol HH
Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
[TBL] [Abstract][Full Text] [Related]
11. Requirement of oestrogens for the sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man.
Pizzi M; Rubessa S; Simonazzi E; Zanagnolo V; Falsetti L; Memo M; Spano PF
J Endocrinol; 1992 Feb; 132(2):311-6. PubMed ID: 1541929
[TBL] [Abstract][Full Text] [Related]
12. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide is a hypothalamic prolactin-releasing neuropeptide in the turkey (Meleagris gallopavo).
el Halawani ME; Silsby JL; Mauro LJ
Gen Comp Endocrinol; 1990 Apr; 78(1):66-73. PubMed ID: 2158920
[TBL] [Abstract][Full Text] [Related]
14. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
15. Anterior pituitary vasoactive intestinal peptide mRNA is colocalised with prolactin mRNA in hyperoestrogenised rats.
Chew LJ; Seah V; Murphy D; Carter D
J Mol Endocrinol; 1996 Jun; 16(3):211-20. PubMed ID: 8782079
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
17. Adenosine and its analogue (-)-N6-R-phenyl-isopropyladenosine modulate anterior pituitary adenylate cyclase activity and prolactin secretion in the rat.
Schettini G; Landolfi E; Meucci O; Florio T; Grimaldi M; Ventra C; Marino A
J Mol Endocrinol; 1990 Aug; 5(1):69-76. PubMed ID: 2397024
[TBL] [Abstract][Full Text] [Related]
18. Rhythmic secretion of prolactin in rats: action of oxytocin coordinated by vasoactive intestinal polypeptide of suprachiasmatic nucleus origin.
Egli M; Bertram R; Sellix MT; Freeman ME
Endocrinology; 2004 Jul; 145(7):3386-94. PubMed ID: 15033917
[TBL] [Abstract][Full Text] [Related]
19. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
Huang SK; Pan JT
Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
[TBL] [Abstract][Full Text] [Related]
20. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
